The HTA Review's final report recommended that consideration be given to allowing the PBAC to conditionalise its recommendations. Why? An analysis reveals the committee is already explicitly conditionalising its recommendations, making them effectively provisional. …
We don't need new laws for conditional outcomes, because they are already embedded in the system
August 21, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech -
Novartis names new Country President following leadership transition
December 16, 2025 - - Latest News -
Mayne Pharma opens expanded manufacturing facility after termination of takeover
December 16, 2025 - - Latest News -
Budget update includes impact of listings, but generally not much else
December 16, 2025 - - Latest News -
The UK reconfirms the direct impact of the transatlantic shift in medicine pricing
December 16, 2025 - - Latest News -
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - - Latest News